ResMed (ASX:RMD) - CEO, Mick Farrell
CEO, Mick Farrell
Source: ResMed
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Resmed (RMD) revenue surges by 23 per cent to $1.1 billion in Q4 FY23
  • The company’s operating profit rose eight per cent, while non-GAAP operating profit grew by 13 per cent
  • ResMed lifted its quarterly dividend by nine per cent, now at 48 cents
  • For FY23, the company posted increased revenue by 18 per cent to $4.2 billion and operating cash flow of $693.3 million
  • RMD shares are trading flat at $33.85

ResMed (RMD) has announced its financial results for Q4 FY23, highlighting RMD revenue increased by 23 per cent to $1.1 billion.

The company also posted a strong operating cash flow of $237.4 million.

The growth was attributed to increasing demand for the company’s cloud-connected flow generator devices and patient interface solutions.

Moreover, ResMed has increased its quarterly dividend by nine per cent to 48 cents. It reflects the company’s strong financial performance.

ResMed’s operating profit experienced an eight per cent rise during the fourth quarter, accompanied by an even more robust 13 per cent increase in non-GAAP operating profit.

For the full year, the company posted increased revenue by 18 per cent to $4.2 billion and operating cash flow of $693.3 million.

ResMed CEO Mick Farrell highlighted the company’s efforts to deliver advanced sleep and digital health solutions that positively impact millions of lives.

“ResMed’s fourth quarter and full-year 2023 results reflect strong double-digit growth as we continue to produce and deliver cloud-connected flow generator device volume to meet the ongoing strong global demand from patients, accompanied by high growth of our market-leading patient interface and software solutions,” he said.

The company also acquired Somnoware, a leader in digital sleep and respiratory care diagnostics software, adding to its focus to enhance patient outcomes and expand its global reach.

RMD shares last traded at $33.85.

RMD by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Worst session in 6 weeks for bourse | July 25, 2024

The ASX200 closed in the red, down nearly 1.3% to 7,861.2 points. All sectors made losses…
The Market Online Video

ASX Market Update: Index falls hard on company earnings | July 25, 2024

The ASX200 has been trading down nearly 1.2% to 7,870 points. Overnight, earnings reports from US…
Saccharomyces cerevisiae yeast, 3D illustration.

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Biotech company Tissue Repair Ltd (ASX:TRP) has seen its share price rise more than 30% on news it had gained TGA (Therapeutic
Closeup graph of Binary option for trading platform

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tech sector companies Ovanti Ltd and Brainchip Holdings Ltd joined Lake Resources Ltd and VHM Ltd…